Autoimmune thyroiditis - Selected etiopathogenic mechanisms;Autoimunitní tyreoiditida - Vybrané etiopatogenetické mechanizmy

Vnitrni Lekarstvi

Volumn 52, Issue 10, 2006, Pages 891-899

  Šterzl, Ivan ^a,b   Hrda P ^a,b   Matucha, P ^a   Potuznikova B ^b   Prochazkova J ^b  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Autoimmune polyglandular syndrome; Autoimmune thyroiditis; Heavy metals; Helicobacter pylori; HLA antigens; Polyglandular activation of autoimmunity

Indexed keywords

HEAVY METAL; HLA ANTIGEN;

ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; GENETIC PREDISPOSITION; HASHIMOTO DISEASE; HELICOBACTER PYLORI; HUMAN; MULTIPLE ENDOCRINE ADENOMATOSIS;

ADULT; ANTIBODIES, BACTERIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER PYLORI; HLA ANTIGENS; HUMANS; HYPERSENSITIVITY; MALE; METALS; MIDDLE AGED; THYROIDITIS, AUTOIMMUNE;

EID: 33749589999     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Muir A, Schatz DA, Maclaren NK. Polyglandular failure syndromes. 3013-3022. In: DeGroot LJ, Besser M, Burger HG. Endocrinology. Philadelphia: WB Saunders 1995: 3013-3022.
2. Šterzl I, Fučíková T, Hrdá P et al. Únavový syndrom u autoimunitní tyreoiditidy s polyglandulární aktivací autoimunity. Vnitř Lék 1998; 44: 456-460.
3. Šterzl I, Vavrejnová V, Matucha P et al. Extrathyroid autoantibodies in autoimmune thyroiditis. Polyendocrine autoantibodies. The Thyroid Gland 1999; 2: 37-43.
4. Volpé R. The immunology of human autoimmune thyroid disease. 217-245. In: Volpé R. Autoimmune endocrinopathies. New Jersey 1999. 217-245.
5. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 1995; 181: 1597-1601.
6. Zamrazil V, Němec J, Šterzl I. Autoimunitní tyreopatie. Klinická biochemie a metabolismus 1995; 3: 71-73.
7. Robles DT, Fain PR, Gottlieb PA et al. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002; 31: 353-368.
8. Wallaschofski H, Meyer A, Tuschy U et al. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res 2003; 35: 120-124.
9. De Maria R, Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today 1998; 19: 121-125.
10. Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev 2005; 3: 20-32.
11. Gianani R, Sarvetnick N. Viruses, cytokines, antigens, and autoimmunity. Proc Natl Acad Sci USA 1996; 93: 2257-2259.
12. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993; 14: 107-120.
13. Bech K, Clemmensen O, Larsen JH et al. Thyroid disease and Yersinia. Lancet 1977; 8020: 1060-1061.
14. de Luis DA, Varela C, de La Calle H et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998; 26: 259-263.
15. De Koster E, De Bruyne I, Langlet P et al. Evidence based medicine and extra-digestive manifestations of Helicobacter pylori. Acta Gastroenterol Belg 2000; 63: 388-392.
16. Bertalot G, Montresor G, Tampieri M et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004; 61: 650-652.
17. Larizza D, Calcaterra V, Martinetti M et al. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab 2006; 91: 176-179.
18. Tomasi PA, Dore MP, Fanciulli G et al. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci 2005; 50: 385-388.
19. Bruce GJ, Hall WB. Nickel hypersensitivity-related periodontitis. Compend Contin Educ Dent 1995; 178(16): 180-174.
20. Eti S, Weisman R, Hoffman R et al. Slight renal effect of mercury from amalgam fillings. Pharmacol Toxicol 1995; 76: 47-49.
21. Hanf V, Forstmann A, Costea JE et al. Mercury in urine and ejaculate in husbands of barren couples. Toxicol Lett 1996; 88: 227-231.
22. Hensten-Pettersen A. Casting alloys: side-effects. Adv Dent Res 1992; 6: 38-43.
23. Larsson A, Warfvinge G. The histopathology of oral mucosal lesions associated with amalgam or porcelain-fused-to-metal restorations. Oral Dis 1995; 1: 152-158.
24. Selden AI, Persson B, Bornberger-Dankvardt SI et al. Exposure to cobalt chromium dust and lung disorders in dental technicians. Thorax 1995; 50: 769-772.
25. Shitova O, Guseva L, Denisova A et al. Immunosupression caused by industrial chemicals in workers of a pharmaceutical factory. In: Abstracts of the 8th International Congress of Immunology. Budapest (Hungary), Aug 1992. Budapest (Hungary): Springer Hungarica 1992: 597.
26. Ionescu G. Allergotoxische Einflüsse von Umweltschadstoffen bei Allergiekranken. Forsch Komplementärmed 1995; 2: 2-8.
27. Skare I, Bergstrom T, Engqvist A et al. Mercury exposure of different origins among dentists and dental nurses. Scand J Work Environ Health 1990; 16: 340-347.
28. Sterzl I, Prochazkova J, Hrda P et al. Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuroendocrinol Lett 1999; 20: 221-228.
29. R Development. Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2005.
30. Figura N, Di Cairano G, Lore F et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999; 50: 817-826.
31. Raymond J, Sauvestre C, Kalach N et al. Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children, Pediatr Infect Dis J 2000; 19: 118-121.
32. Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol 1996; 16: 105-115.
33. Negrini R, Savio A, Poiesi C et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655-665.
34. Roos A, Schilder-Tol EJ, Chand MA et al. HgCl2 and IL4 differentially modify expression of major histocompatibility complex class II molecules RT1.B and RT1.D in B lymphocytes from brown Norway and Lewis rats. Transplant Proc 1997; 29: 1675-1676.